SecBot SecBot
8-K ·Filed Jun 22, 2026

SKIN

SkinHealth Systems Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001628280-26-044620
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The settlement removes a material overhang from the securities class action at a low net cost to the company ($3M). Monitor for court approval and any appeals. If approved, this is a clean resolution with no ongoing liability.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
SKIN ▲ +1.23% at T+60d
NEUTRAL call +1.23% · α vs SPY -2.02% · entry $0.6668 → $0.6750
Entry = T+0 close
Jun 22, 2026
via day close
T+1d
-1.02%
call -1.02% · α -0.97%
$0.6600
settled 4mo ago
T+5d
+6.87%
call +6.87% · α +5.86%
$0.7126
settled 4mo ago
T+20d
+18.22%
call +18.22% · α +17.06%
$0.7883
settled 3mo ago
T+60d
+1.23%
call +1.23% · α -2.02%
$0.6750
settled 6w ago

Price Chart

Loading chart...

Executive Summary

SkinHealth Systems Inc. (SKIN) filed an 8-K disclosing a proposed settlement of a securities class action for $18M total, of which the company pays only $3M from its own funds and $15M from insurers. The settlement is subject to court approval and resolves claims against the company and named executives for the period May 2022 to Nov 2023. No admission of wrongdoing.

Key Facts

  • Total settlement amount: $18,000,000
  • Company out-of-pocket: $3,000,000
  • Insurance contribution: $15,000,000
  • Plaintiffs' attorneys' fees capped at 30% of settlement ($5,400,000)
  • Settlement covers class period May 10, 2022 to November 13, 2023
  • No admission of liability or wrongdoing
  • Subject to court approval; no guarantee of approval

Financial Impact

Company's net cash outlay is $3M (3.5% of $86M market cap); insurance covers 83% of total. Attorneys' fees up to $5.4M are deducted from the settlement fund, not an additional company cost.

cashliabilitylitigation expense

Risk Factors

  • Court may not approve the settlement
  • Objections or appeals could delay or increase costs
  • Attorneys' fees and administrative expenses reduce net recovery to class, but do not affect company's cash outlay

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
7% bullish (14 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-044620
Document: 0001628280-26-044620-index-headers.html0001628280-26-044620
Document: 0001628280-26-044620-index.html0001628280-26-044620
Document: 0001628280-26-044620.txt0001628280-26-044620
8 reports for SKIN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SKIN — sortable, filterable
TypeNow
Oct 22, 2026
5d ago
Press Release
NEUTRAL ★ 1/10
$11.10awaiting T+5—$10.43 (−5.99%)
Oct 14, 2026
13d ago
8-K
NEUTRAL ★ 4/10
$11.56 $11.03▼ −4.58%▼ −5.04%$10.43 (−9.78%)
Oct 6, 2026
20d ago
8-K
BULLISH ★ 5/10
$0.5899 $11.56▲ +1859.65%▲ +1860.63%$10.43 (+1668.08%)
Jul 21, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$0.7616awaiting T+5—$10.43 (+1269.47%)
Jun 22, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$0.6668 $0.7126▲ +6.87%▲ +5.86%$10.43 (+1464.17%)
Apr 29, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$0.8040 $0.8990▲ +11.82%▲ +8.71%$10.43 (+1197.25%)
Apr 22, 2026
26w ago
8-K
NEUTRAL ★ 5/10
$0.8260 $0.8040▼ −2.66%▼ −4.14%$10.43 (+1162.70%)
Mar 12, 2026
32w ago
Press Release
MIXED ★ 6/10
$1.27 $1.13▼ −11.02%▼ −8.91%$10.43 (+721.25%)
Showing 8 of 8

US Market Status

Market Open — Closes in 5h 22m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 22, 2026